USA – An infant formula product previously recalled by Dairy Manufacturers Inc. has tested positive for Cronobacter, a bacterium that can cause severe and life-threatening infections in infants.
The contaminated product, Crecelac Infant 0-12, bearing the lot code 24 039 1 CHE 352-1 and UPC 8 50042 40847 6, was manufactured at the facility in Monterey, Mexico, and sold in Texas retail stores during March, April, and May of 2024.
Dairy Manufacturers Inc. has issued a statement advising consumers to check their formula stock for the affected product and refrain from using it.
“We sincerely apologize for any inconvenience or concern this may cause and assure our customers that we are taking all necessary steps to ensure the safety, quality, and compliance of our products,” the company stated.
The discovery of Cronobacter contamination has escalated concerns surrounding the recalled product, which was initially recalled due to non-compliance with the FDA’s pre-launch registration requirements.
With the additional risk posed by Cronobacter spp., the Centers for Disease Control and Prevention (CDC) authorities are urging consumers to take immediate precautions.
“Cronobacter infections are rare but extremely serious, especially for infants under two months old. These infections can lead to severe symptoms, including seizures, hydrocephalus (fluid build-up in the brain), developmental delays, and can be fatal.”
The CDC estimates that Cronobacter infections result in death in about 20% of U.S. infants and 40% of infants globally who develop meningitis or bloodstream infections.
This incident highlights the ongoing risks associated with powdered infant formula and the critical need for stringent safety measures in its production and handling.
Health authorities emphasized the importance of vigilant monitoring and robust regulatory frameworks to protect infants from potential health hazards in their food supply.
As investigations continue, health authorities also urged consumers to remain vigilant and report any adverse health effects associated with the consumption of infant formula products.
Meanwhile, the FDA and CDC will closely monitor the situation and provide updates as more information becomes available.
In 2022, a Cronobacter sakazakii contamination discovered at Abbott Nutrition’s manufacturing plant in Sturgis, Michigan, led to a large-scale formula recall and the temporary shutdown of one of the largest U.S. infant formula producers.
The FDA has since formulated a strategy to help prevent future illnesses linked to powdered infant formula consumption.
Measures include strengthening regulatory activities, reviewing infant formula production rules and testing requirements, and improving communication to consumers about how to safely prepare and store powdered formula.
Subscribe to our food and agriculture industry email newsletters that provide busy executives like you with the latest news insights and trends from Africa and the World. SUBSCRIBE HERE
